Completed
Safety, Tolerability, and Pharmacokinetic Study of TV-44749 in Chinese Patients With Schizophrenia
NCT06253546
- Conditions
- Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
- Locations
-
- Teva Investigational Site 88049 Beijing, China
- Teva Investigational Site 88048 Beijing, China
- Teva Investigational Site 88047 Guangzhou, China
- Teva Investigational Site 88046 Shanghai, China